- Posted July 11, 2014 by
- Cannabis Sector Gains Market Security as DEA is Blocked from Targeting Medical Marijuana
- DGRI Could Become the Next Big Board Medical Marijuana Sector Company
- Dutch Gold is Launching a Marketing Campaign to Take Over the Cannabis Sector's Payment Processing
- Dutch Gold Resources, Inc. (OTCBB: DGRI) Expects to Capitalize on the Emerging $180M Medical Marijuana Sector Merchant Services Industry
- Dutch Gold Resources, Inc. (OTCBB: DGRI) Follows the Footsteps of OTC Heroes into an Emerging $2B+ Annual Industry
DGRI acquired Cannabis Potency Test Kit from Tetra Micro Labs, Inc..
On Thursday, July 10th of 2014, Dutch Gold Resources, Inc. (OTCPK: DGRI) announced that they had acquired a patented technology that will expedite the development of their cannabis potency test kit. The company expects to begin building their distribution network for the new product later this month, and they anticipate that they will be launching their own direct-to-customer sales initiative later in this this quarter.
This announcement couldn't come at a better time, as recent reports of cannabis users consuming more highly concentrated dosages than desired have been surging as of late. Seeing as cannabis is still a fairly new substance from a legal perspective, there is still much learning to be done by users and regulators. As people are learning the dosages and concentrations for them, potency tests like the one that DGRI will be producing will be in high demand. The company has actually already placed an ad for distributors claiming that it will be a very exclusive opportunity, as demand is expected to be very high and they want to work with a tight-knit group of businesses. In addition to consumer use, the test kits could be used by regulators, police, or other law enforcement in the future as well to enforce potency restrictions that may arise. This could lead to solidly sized government purchases. The contract for this acquisition has already been filed with the SEC, and it seems that things are truly under way.
As one of the first producers and intellectual property holders in this high-demand niche (test kits) that is expected to be valued around $450 million, DGRI is positioned to make shareholders happy, and the company intends to become current very quickly. Additionally, in order to maintain shareholder value, the company has refrained from diluting lately. As the old adage goes, the early bird gets the worm.
With companies like MJNA, MINE, ERBB, GRCU, and HEMP making attracting huge pools of investors and in some cases customers with their cannabis industry related products, it's no surprise that companies like DGRI would see similar successes upon releasing news about entry into the at home MJ test kit.